HealthRX Review: Pricing, Process & Key Considerations
A fact-checked look at HealthRX’s compounded GLP-1 program, including current pricing, clinician review, fulfillment and important limitations.
Affiliate disclosure: GLP Guidebook may earn a commission when you use a HealthRX affiliate link. This does not change your price. Medical treatment requires clinician review.
Key points
- HealthRX currently advertises compounded semaglutide from $99/month on a 12-month prepaid plan and compounded tirzepatide from $179/month on a 12-month prepaid plan.
- HealthRX says independent U.S.-licensed clinicians make prescribing decisions and that approval is not automatic.
- The compounded medications offered through the program are not FDA-approved.
What HealthRX says its program includes
HealthRX describes itself as a marketplace platform connecting patients with independently licensed clinicians and a licensed Section 503A compounding pharmacy. Its current pricing page says plans include provider review, the prescription when clinically appropriate, medication, overnight shipping, provider messaging, dose management and refill coordination.
What matters before you click
The biggest distinction is regulatory status: the program described here involves compounded medication. Compounded medications are not FDA-approved. The FDA does not review them before marketing for safety, effectiveness or quality in the same way it reviews approved drugs.
What to verify before making a decision
Confirm the exact product, FDA approval status, prescriber, dispensing pharmacy, total amount billed today, renewal terms, cancellation rules and available clinical follow-up. Program terms can change, so merchant-specific claims should be checked at the source.
Related guides
Sources & update standard
Merchant-specific claims are based on HealthRX’s currently published materials. Regulatory distinctions are checked against FDA materials. We date-stamp substantive reviews because pricing, supply conditions and compounding policy can change.